Clinical trial · Observational
Chemotherapy Resistance and Sensitivity Testing in Lung Tumors
NCT01570855CI-TRIAL-00021924completedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The purpose of this study is to screen chemotherapy drugs currently used to treat lung cancer and determine the most effective treatment based on results of chemo sensitivity testing on the patients own cancer cells in the laboratory. The results of this screening will not influence the patients treatment.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Lung Cancer | Malignant Lung Neoplasm | CURATED_EXACT | 0.92 |
Interventions
Interventions (0)
Data not yet available
No intervention recorded.
Design
Arms and outcomes
Arms (0)
[]Primary outcomes (1)
- measure
- Tumor size
- timeFrame
- 3 months
- description
- Tumor response will be evaluated (progression/regression) by CT scan at 3 months from therapy start. Clinical response to chemotherapy of lung cancer tumor cells versus lung cancer stem cells to standard of care chemo drugs will be evaluated and correlated to predicted drug by ex vivo assay.
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * suspected or confirmed diagnosis of lung cancer * undergoing a fine needle aspiration, core biopsy, or excisional biopsy for diagnosis. * Chemotherapy must be clinically indicated for treatment of the patient's qualifying disease * Patient must be at least 18 years of age * Patient must have signed an IRB approved informed consent form for the data collection study prior to entry of data into the enrollment form in the database. Exclusion Criteria: * Patient pathology shows benign pathology for sample submitted * Patient is not indicated to receive chemotherapy for their disease
References
Publications (0)
Data not yet available
No reference posted for this study.